1. [BP.10.02] NOX4 DEFICIENCY LEADS TO HYPERTENSION AND VASCULAR-RENAL FIBROSIS WITH ENHANCED EFFECTS IN ANG II-DEPENDENT HYPERTENSION. (September 2017) Authors: Lacchini, S.; Harvey, A.; Lopes, R.; Montezano, A.C.; Rios, F.; Schroder, K.; Brandes, R.P.; Touyz, R.M. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [PP.03.16] INCREASED ROS GENERATION INVOLVES MITOCHONDRIA IN MR-OVEREXPRESSING ADIPOCYTES – IMPACT ON VASCULAR FUNCTION. (September 2016) Authors: Cat, A. Nguyen Dinh; Friederich-Persson, M.; Dulak-Lis, M.G.; Sanchez, A.; Nosalski, R.; Montezano, A.C.; Guzik, T.J.; Jaisser, F.; Touyz, R.M. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ang-(1-7) non-peptide mimetic (AVE0991) prevents atherogenesis in ApoE-/- mice by inhibiting perivascular macrophage infiltration and activation. Issue 1 (July 2015) Authors: Skiba, D.S.; Nosalski, R.; Mikolajczyk, T.; Olszanecki, R.; Jawien, J.; Rios, F.; Montezano, A.C.; Touyz, R.M.; Guzik, T.J. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CETP inhibitors torcetrapib, dalcetrapib, and anacetrapib induce adipocyte-derived aldosterone production through Nox and STAT3 activation. Issue 1 (July 2015) Authors: Rios, F.J.; Neves, K.B.; Cat, A. Nguyen Dinh; Even, S.; Palacios, R.; Jenkins, C.; Carswell, A.; Montezano, A.C.; Touyz, R.M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LB03.07: ANTIHYPERTENSIVE THERAPY AND RISK OF ADMISSIONS FOR MOOD DISORDERS. (June 2015) Authors: Boal, A.; Smith, D.; Muir, S.; Touyz, R.M.; Dominiczak, A.F.; Padmanabhan, S. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PP.30.39: HIGH DISCONTINUATION RATE OF ALISKIREN FOLLOWING ANTIBIOTIC THERAPY IN HYPERTENSIVE PATIENTS. (June 2015) Authors: Kassi, M.; Mccallum, L.; Muir, S.; Touyz, R.M.; Dominiczak, A.F.; Padmanabhan, S. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. VASCULAR EFFECTS OF ANTI-CANCER CISPLATIN THERAPY. (June 2018) Authors: Cameron, Alan C.; Hall, M.; Rios, F.; Waterston, A.; White, J.; Touyz, R.M.; Lang, N.N. Journal: Journal of hypertension Issue: Volume 36(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗